JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma.
Zak J, Pratumchai I, Marro BS, Marquardt KL, Zavareh RB, Lairson LL, Oldstone MBA, Varner JA, Hegerova L, Cao Q, Farooq U, Kenkre VP, Bachanova V, Teijaro JR.
Zak J, et al. Among authors: marro bs.
Science. 2024 Jun 21;384(6702):eade8520. doi: 10.1126/science.ade8520. Epub 2024 Jun 21.
Science. 2024.
PMID: 38900864
Clinical Trial.